Childhood Acute Eosinophilic Leukemia
5 clinical trials · Condition
◉ Watch Childhood Acute Eosinophilic Leukemia
| Record | Firm | Date |
|---|---|---|
| Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia (NCT01076569) | Children's Oncology Group | 2010-03-01 |
| Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia (NCT00666588) | National Cancer Institute (NCI) | 2008-04-01 |
| Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00369317) | Children's Oncology Group | 2007-03-01 |
| Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00096148) | National Cancer Institute (NCI) | 2004-10-01 |
| Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia (NCT00006363) | National Cancer Institute (NCI) | 2000-11-01 |
Track Childhood Acute Eosinophilic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.